Antiviral peptides

Details Antiviral peptides Antiviral peptides

1984-08-30

1986-12-02

Phillips, Delbert R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 14, 514 15, 514 16, 514 17, 514 18, 530325, 530330, 530326, 530327, 530328, 530329, A61K 3702, C07K 710, C07K 708, C07K 706, C07K 510

Patent

active

046265244

ABSTRACT:
The present invention provides peptides of a sequence which is similar or identical to the amino terminal sequence of the F.sub.1 chain of mumps virus. A variety of peptides are disclosed ranging from oligopeptides to dodecapeptides.

REFERENCES:
Richardson, C. D. et al., Virology, 105: 205-222 (1980).
Miller, F. A. et al., Applied Microbiology, 16: 1489-1496 (1968).
Nicolaides, E. et al., Journal of Medical Chemistry, 11: 74-79 (1968).
Nornby, E., Virology, 44: 599-608 (1971).

Affiliated with

Also associated with

Rating

Antiviral peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2292686